Kayne Anderson Rudnick Investment Management
JUNO

Kayne Anderson Rudnick Investment Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,510
Closed -$1.85M – 363
2017
Q4 		$1.85M Buy
40,510
+57
+0.1% +$2.84K 0.02% 269
2017
Q3 		$1.81M Buy
+40,453
New +$1.38M 0.02% 268

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Kayne Anderson Rudnick Investment Management's JUNO Position: Q1 2018 in Review

Kayne Anderson Rudnick Investment Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 40,510 shares — an estimated $1.85M sold.

Kayne Anderson Rudnick Investment Management first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $1.85M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Kayne Anderson Rudnick Investment Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 40,510 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.85M.
  • Kayne Anderson Rudnick Investment Management first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Kayne Anderson Rudnick Investment Management's Juno Therapeutics, Inc. position peaked at $1.85M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2018, filed 9 May 2018.